Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00965198 · ClinicalTrials.gov registry record

Comparison of Infection Rates Among Patients Using Two Catheter Access Devices

A clinical trial of Bacteremia and Catheter-Related Infections, sponsored by Emory University.

Completed
Registry status
10,000
Enrollment target
2
Study locations

NCT00965198 is a study of Bacteremia and Catheter-Related Infections that has completed, run by Emory University. The registered enrollment target is 10,000 participants, above the 6,668-participant average among 11 other Bacteremia trials with a reported enrollment target (50% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00965198, a study of Bacteremia and Catheter-Related Infections, has completed, sponsored by Emory University.

COMPLETED
Registry status
10,000 participants
Enrollment target
2
Study locations

Study Summary

Intravenous catheters are placed in nearly every hospitalized patient. These catheters, since they are breaks in skin integrity, are potential sources of infection that occur in the bloodstream. Bloodstream infections can result in higher rates of death and lengths of hospital stay, as well as increase healthcare costs. Blood is drawn or medications delivered through a catheter access device attached to the catheter. In looking at new ways to decrease infections associated with healthcare, the investigators plan to test whether the use of a silver-coated catheter access device (VLINK) compared to the standard, non-coated device (CLEARLINK) can reduce infection rates. These devices are identical in design other than the silver coating of the VLINK, that imparts a brown color to the device. Silver can prevent the growth of bacteria inside the device (biofilm formation) in the laboratory, but this has never been proven in patients. The investigators propose to do a crossover study in two Emory-owned hospitals (Emory University Hospital and Emory University Hospital at Midtown), anticipated to last 10 months. Currently, both types of devices, (standard and silver-coated) are FDA approved for clinical use and are in use at both hospitals. The investigators plan to have each hospital use only one type of catheter access device for a period of time (approximately 5 months), and then switch ("crossover") to other type of device for the rest of the study. All patients admitted to either hospital (excluding newborns and patients with infections attributed to hemodialysis catheters) will be enrolled since both devices meet the standard of care. During the study, the infection prevention department, as a continuing part of their regular duties will measure infection rates. A small subset of catheters that are removed during routine clinical care (none will be taken out solely for the study) will be sent to CDC to determine the amount of bacteria inside catheters and catheter a

Study Locations (2)

Georgia

  • Emory University Hospital - Atlanta
  • Emory University Hospital Midtown - Atlanta

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2009-11
Est. Completion 2011-07

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT00965198

The ClinicalTrials.gov registry entry for NCT00965198 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 6,668-participant average among 11 other Bacteremia trials with a reported enrollment target (50% higher). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Bacteremia appearing as the primary indexed condition, and to 0 interventions.

NCT00965198 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT00965198 about?

NCT00965198 is a clinical study titled "Comparison of Infection Rates Among Patients Using Two Catheter Access Devices". Intravenous catheters are placed in nearly every hospitalized patient. These catheters, since they are breaks in skin integrity, are potential sources of infection that occur in the bloodstream. Bloodstream infections can result in higher rates of death and lengths of hospital stay, as well as incre...

What is the current status of trial NCT00965198?

This trial is currently completed. The enrollment target is 10,000 participants. The study started on 2009-11. Estimated completion is 2011-07.

What conditions does trial NCT00965198 study?

This clinical trial studies the following conditions: Bacteremia, Catheter-Related Infections.

Who is sponsoring clinical trial NCT00965198?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00965198 being conducted?

This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bacteremia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.